NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION
Rhea-AI Summary
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals across 11 states, announced three significant updates: preliminary Q2 2025 results, a Form 10-Q filing delay, and a $25 million stock repurchase program.
The company reported strong Q2 2025 performance with revenue of $244.0 million, up 220.7% year-over-year, and gross profit of $124.9 million (51.2% margin). Total hospital visits increased by 10.6% to 45,573. For H1 2025, revenue reached $455.8 million, up 217.5%, with gross profit of $243.3 million.
The Form 10-Q filing delay is due to non-cash accounting adjustments related to stock-based compensation for under-construction hospitals. The company expects to file within the five-day grace period and confirms these adjustments won't affect revenue, gross profit, or operations.
Positive
- Revenue surged by 220.7% YoY to $244.0 million in Q2 2025
- Gross profit margin improved significantly to 51.2% from 29.7% YoY
- Hospital visits increased 10.6% to 45,573 in Q2 2025
- Strong cash position of $96.6 million as of June 30, 2025
- $25 million stock repurchase program announced to enhance shareholder value
Negative
- Delay in filing Q2 2025 Form 10-Q due to accounting adjustments
- Cancellation of scheduled earnings conference call
- Financial results are preliminary and subject to adjustments
News Market Reaction
On the day this news was published, NUTX declined 16.40%, reflecting a significant negative market reaction. Argus tracked a peak move of +2.4% during that session. Argus tracked a trough of -18.0% from its starting point during tracking. Our momentum scanner triggered 32 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $121M from the company's valuation, bringing the market cap to $617M at that time.
Data tracked by StockTitan Argus on the day of publication.
The Company expects that any non-cash adjustments related to the treatment of these obligations will have no effect on its revenue, gross profit, liquidity, working capital or number of patient visits.
The Company is working diligently with its auditors to address the matter in a timely and efficient manner. As disclosed in its Form 12b-25, the Company expects to file the Form 10-Q for the period ended June 30, 2025 within the SEC-prescribed five calendar day grace period.
The Company provided select preliminary unaudited financial results for the three and six months ended June 30, 2025. The preliminary financial information presented below reflects management's current views with respect to the Company's financial results. These preliminary results remain subject to the completion of normal quarter-end and fiscal-end accounting procedures and closing adjustments. Nutex Health will release its full financial results as promptly as reasonably practicable.
The Company hereby announces the cancellation of the conference call that was originally scheduled Friday, August 15, 2025, at 10:30 a.m. ET. The Company will reschedule the conference call as soon as possible where it will discuss 2nd Quarter financials as well as other topics relevant to the Company.
Financial highlights for the three months ended June 30, 2025:
- Total revenue was
$244.0 million $76.1 million 220.7% . Revenue from mature hospitals, which are hospitals opened prior to December 31, 2021, increased by203.2% in 2025 compared to 2024. - Gross profit was
$124.9 million 51.2% of total revenue, for the three months ended June 30, 2025 as compared to gross profit of$22.6 million 29.7% of total revenue, for the same period in 2024. - Total visits at the Hospital Division were 45,573 for the three months ended June 30, 2025, as compared to 41,208 for the same period in 2024, an increase of 4,365 or
10.6% . Visits at mature hospitals increased by0.6% in the three months ended June 30, 2025 as compared to the same period in 2024. - As of June 30, 2025, the Company had total assets of
$855.1 million $96.6 million
Financial highlights for the six months ended June 30, 2025:
- Total revenue was
$455.8 million $143.5 million 217.5% . Revenue from mature hospitals, which are hospitals opened prior to December 31, 2021, increased by195.2% in 2025 compared to 2024. - Gross profit was
$243.3 million 53.4% of total revenue, for the six months ended June 30, 2025, as compared to gross profit of$32.7 million 22.8% of total revenue, for the same period in 2024. - Total visits at the Hospital Division were 93,842 for the six months ended June 30, 2025, as compared to 81,276 for the same period in 2024, an increase of 12,566 or
15.5% . Visits at mature hospitals increased by3.0% in the six months ended June 30, 2025, as compared to the same period in 2024.
Share Repurchase Program
The Board of Directors has authorized a stock repurchase program of up to
The timing of any repurchases and the number of shares repurchased are subject to the discretion of the Company and may be affected by various factors, including general market and economic conditions, the market price of the Company's common stock, the Company's earnings, financial condition, capital requirements and levels of indebtedness, legal requirements, and other factors that management may deem relevant. The share repurchase program authorization does not obligate the Company to acquire any shares of its common stock and may be amended, suspended or discontinued at any time.
About Nutex Health Inc.
Headquartered in
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 24 facilities in 11 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
- This Press Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including, but not limited to, changes in laws or regulations applicable to our operations, in particular, changes to the regulations promulgated under the No Surprises Act, any statements about our business, financial condition, operating results, plans, objectives, expectations and intentions, any guidance on, or projections of, earnings, revenue or other financial items, or otherwise, and our future liquidity, including cash flows; any statements of any plans, strategies, and objectives of management for future operations, such as the material opportunities that we believe exist for our Company; any statements concerning proposed services, developments, mergers or acquisitions; or strategic transactions; any statements regarding management's view of future expectations and prospects for us; any statements about prospective adoption of new accounting standards or effects of changes in accounting standards; any statements regarding future economic conditions or performance; any statements of belief; any statements of assumptions underlying any of the foregoing; and other statements that are not historical facts. Forward-looking statements may be identified by the use of forward-looking terms such as "anticipate," "could," "can," "may," "might," "potential," "predict," "should," "estimate," "expect," "project," "believe," "think," "plan," "envision," "intend," "continue," "target," "seek," "contemplate," "budgeted," "will," "would" and the negative of such terms, other variations on such terms or other similar or comparable words, phrases or terminology.
- Forward-looking statements involve risks and uncertainties and are based on the current beliefs, expectations, and certain assumptions of management. Some or all of such beliefs, expectations, and assumptions may not materialize or may vary significantly from actual results. Such statements are qualified by important economic, competitive, governmental, and technological factors that could cause our business, strategy, or actual results or events to differ materially from those in our forward-looking statements. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements described under, but not limited to, the heading "Item 1A. Risk Factors" included in the Annual Report of Nutex Health Inc. on Form 10-K for the year ended December 31, 2024 and other filings of the Company with the United States Securities and Exchange Commission. Although we believe that the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change, and significant risks and uncertainties that could cause actual conditions, outcomes and results to differ materially from those indicated by such statements. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequence to or effects on the Company or its business or operations. The Company assumes no obligations to update any such forward-looking statements.
View original content:SOURCE Nutex Health, Inc.
FAQ
What were Nutex Health's (NUTX) Q2 2025 revenue and growth?
Why is Nutex Health (NUTX) delaying its Q2 2025 10-Q filing?
How much is Nutex Health's (NUTX) stock repurchase program?
What was Nutex Health's (NUTX) hospital visit growth in Q2 2025?
What is Nutex Health's (NUTX) current cash position?
